GT-3RT 20

Retatrutide is a novel investigational peptide that acts as a triple hormone receptor agonist, targeting the glucagon, GIP, and GLP-1 receptors simultaneously. By activating these three pathways, it is designed to enhance metabolic regulation and significantly influence weight management and glucose control. Research into this compound is currently focused on its potential efficacy for treating obesity and related metabolic conditions through these multi-receptor interactions.